Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
Taysha Gene Therapies (TSHA) Ownership Overview
12.22% Insiders
9.13% Mutual Funds
0.02% Other Institutional Investors
11.46% ETFs
67.17% Public Companies and
Individual Investors
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. Approximately 20.61% of the company’s stock is owned by Institutional Investors, 12.22% is owned by Insiders, and 67.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 06, 2026 | xxxxxxxxxxxxx | $7481 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $547469 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $485042 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $840196 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $994691 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $1457500 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $14971907 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,601,110 | Insider | 8.91% | 113,156,906 | |
| 23,555,648 | Institution | 8.20% | 104,115,964 | |
| 11,341,569 | Institution | 3.95% | 50,129,735 | |
| 10,267,434 | Institution | 3.57% | 45,382,058 | |
| 9,249,081 | Institution | 3.22% | 40,880,938 | |
| 7,235,102 | Institution | 2.52% | 31,979,151 | |
| 6,501,883 | Institution | 2.26% | 28,738,323 | |
| 4,443,802 | Insider | 1.55% | 19,641,605 | |
| 4,004,756 | Institution | 1.39% | 17,701,022 | |
| 2,722,165 | Institution | 0.95% | 12,031,969 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,249,081 | Institution | 3.22% | 40,880,938 | |
| 6,501,883 | Institution | 2.26% | 28,738,323 | |
| 2,326,146 | Institution | 0.81% | 10,281,565 | |
| 2,240,868 | Institution | 0.78% | 9,904,637 | |
| 1,242,805 | Institution | 0.43% | 5,493,198 | |
| 940,476 | Institution | 0.33% | 4,156,904 | |
| 695,980 | Institution | 0.24% | 3,076,232 | |
| 493,498 | Institution | 0.17% | 2,181,261 | |
| 413,625 | Institution | 0.14% | 1,828,223 | |
| 379,136 | Institution | 0.13% | 1,675,781 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,851,650 | Institution | 2.39% | 31,037,975 | |
| 6,242,238 | Institution | 2.17% | 28,901,562 | |
| 5,226,265 | Institution | 1.82% | 23,465,930 | |
| 2,425,474 | Institution | 0.84% | 10,987,397 | |
| 1,793,905 | Institution | 0.62% | 8,054,633 | |
| 1,684,346 | Institution | 0.59% | 7,562,714 | |
| 1,094,477 | Institution | 0.38% | 4,957,981 | |
| 1,073,627 | Institution | 0.37% | 4,970,893 | |
| 740,773 | Institution | 0.26% | 3,429,779 | |
| 598,759 | Institution | 0.21% | 2,772,254 |
FAQ
Who Owns Taysha Gene Therapies (TSHA)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 12.22% is held by insiders, and 67.17% is held by retail investors.
What percentage of Taysha Gene Therapies (TSHA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.02% of Taysha Gene Therapies (TSHA) stock is held by institutional investors.
What percentage of Taysha Gene Therapies (TSHA) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.17% of Taysha Gene Therapies (TSHA) stock is held by retail investors.
Who owns the most shares of Taysha Gene Therapies (TSHA)?
Paul B Manning owns the most shares of Taysha Gene Therapies (TSHA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.